Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
11C-Acetate PET/CT in Metastatic Prostate Cancer
NCT02715583Phase 1Completed
- Sponsor
- Abramson Cancer Center
- Start
- Mar 2016
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of carbon-11 acetate in prostate cancer (PCa), sponsored by Abramson Cancer Center. Primary endpoint: Fold change in SUVmax at 1 year. Started Mar 2016; status: completed.
02
Drugs
carbon-11 acetate
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02715583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02715583.